{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042947","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2026-09-16T21:05:23+00:00","discovered_at":"2026-09-16T21:06:00.311843+00:00","generated_at":"2026-09-16T21:06:10.100557+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ChronoScale extends $2M loan maturity to Nov 12, 2026; permits Ekso Bionics sale","bullets":["Term loan of $2.0M outstanding extended to Nov 12, 2026 from Sept 12, 2026 via amendment with B. Riley Commercial Capital.","Amendment allows sale of Guarantor Ekso Bionics, Inc. as Permitted Disposition, auto-releasing Lender's liens on sold assets/capital stock.","Waiver dated Apr 23, 2026: Proposed Financing does not accelerate maturity but qualifies as Qualified Financing for conversion right.","Loan Parties confirm $2M principal outstanding and no defenses; all other Note terms unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042947","json":"https://secwatch.observer/filing/0001493152-26-042947.json","markdown":"https://secwatch.observer/filing/0001493152-26-042947.md","text":"https://secwatch.observer/filing/0001493152-26-042947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226042947/0001493152-26-042947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226042947/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T21:06:10.100557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}